In another study [32], the authors constructed a prognostic risk scoring system containing 6 genes (SCUBE3, RDH16, SPC24, SPC25, CCDC69 and DGAT2), suggesting that these mRNAs may serve a driving role in the progression of Her2-positive BC. This evidence concerns the gene ERBB2 and breast cancer.